Previous Close | 1.8 |
1-Year Change | -69.65% |
6-Months Change | -17.05% |
3-Months Change | 10.43% |
Moving Avg (50d) | 1.5674 |
Moving Avg (200d) | 2.0201 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 44.1M |
Beta (3-Years) | 1.09 |
Revenue Growth (ttm) | 111.62% |
Net Profit Margin (ttm) | -272.67% |
Return On Assets (ttm) | -45.4% |
EPS (ttm) | -2.32 |
PE Ratio (ttm) | -0.78 |
Dividend Yield | 0% |
Asset Description: | Aadi Bioscience, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-08-26 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.764 | 1.71 | 1.674 | 1.62 | 1.53 | 1.44 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |